A Wisconsin man has been bitten by snakes hundreds of times, and scientists are studying his blood to treat snakebite.

Fulcrum Therapeutics, Inc. ( NASDAQ: FULC) Q1 2025 Earnings Conference Call May 1, 2025 8:00 AM ET Alex Sapir – President and Chief Executive Officer Alan Musso – Chief Financial Officer Iain Fraser – ...

A Bahrain study shows CT scans to check for blood clots in lung blood vessels increased significantly in people with sickle ...

April marks National Minority Health Month, which highlights health disparities affecting diverse communities. As part of its ...

The next Red Cross Blood Drive, sponsored by The Optimist Club of Senoia and the Senoia United Methodist Church, will be on ...

HealthDay News — For children with sickle cell anemia (SCA), hydroxyurea has sustained clinical benefits in terms of reducing emergency department visits and hospital days, according to a study ...

Martin Mwita, 20, is the first patient in St. Louis and among the first across the country to receive a new gene therapy for ...

One of the Trump administration’s top health officials said Friday that the federal government is working to expand access to ...

Robert F. Kennedy Jr. announces sickle-cell treatment program in Charleston while assuring SC Sen. Tim Scott that federal ...

Sickle cell has been overlooked for far too long. Fortunately, there are new breakthroughs in sickle cell treatment that you ...

Source: Childhood on the Brink in Zimbabwe’s Midlands By Gamuchirai Masiyiwa, GPJ Zimbabwe This story was originally ...

Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...